Published in J Clin Invest on June 01, 1975
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine. Br Med J (Clin Res Ed) (1984) 2.28
Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest (2005) 1.81
Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest (1977) 1.36
Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J Clin Invest (1984) 1.23
Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest (1979) 1.15
IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J Clin Invest (2011) 1.06
Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting. J Clin Invest (1979) 0.99
Defending plasma T3 is a biological priority. Clin Endocrinol (Oxf) (2014) 0.97
What is the best test for monitoring levothyroxine therapy? Can Med Assoc J (1981) 0.75
THE SYNTHESIS OF (13)C9-(15)N-LABELED 3,5-DIIODOTHYRONINE AND THYROXINE. Synth Commun (2012) 0.75
Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest (1970) 3.64
DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING. J Clin Endocrinol Metab (1964) 3.19
Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation. J Clin Invest (1966) 2.87
Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease. J Clin Invest (1956) 2.74
Determination of triiodothyronine concentration in human serum. J Clin Invest (1969) 2.56
Disappearance from serum of I131-labeled l-thyroxine and l-triiodothyronine in euthyroid subjects. J Clin Invest (1954) 2.33
The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man. J Clin Invest (1971) 2.11
Quantitation of extrathyroidal conversion of L-thyroxine to 3,5,3'-triiodo-L-thyronine in the rat. J Clin Invest (1971) 1.94
Determination of iodothyronine absorption and conversion of L-thyroxine (T 4 ) to L-triiodothyronine (T 3 ) using turnover rate techniques. J Clin Invest (1973) 1.90
An improved method for chromatography of iodothyronines. J Clin Endocrinol Metab (1968) 1.84
The kinetics of distribution between plasma and liver of 131-I-labeled L-thyroxine in man: observations of subjects with normal and decreased serum thyroxine-binding globulin. J Clin Invest (1966) 1.73
Acceleration of thyroxine and triiodothyronine turnover during bacterial pulmonary infections and fever: implications for the functional state of the thyroid during stress and in senescence. J Clin Endocrinol Metab (1967) 1.55
Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. J Clin Invest (1972) 1.44
Differences in primary cellular factors influencing the metabolism and distribution of 3,5,3'-L-triiodothyronine and L-thyroxine. J Clin Invest (1970) 1.43
Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131-I and albumin-125-I. J Clin Invest (1967) 1.42
Conversion of thyroxine to triiodothyronine in normal human subjects. Science (1970) 1.42
Complete solution of the three-compartment model in steady state after single injection of radioactive tracer. Am J Physiol (1959) 1.41
The effects of an acute load of thyroxine on the transport and peripheral metabolism of triiodothyronine in man. J Clin Invest (1970) 1.41
An analysis of published data on thyroxine turnover in human subjects. J Clin Endocrinol Metab (1966) 1.37
WHOLE-BODY COUNTING OF 131-I-LABELED TRIIODOTHYRONINE. J Clin Endocrinol Metab (1964) 1.34
The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. J Clin Invest (1970) 1.34
Formation of iodoprotein during the peripheral metabolism of 3,5,3'-triiodo-L-thyronine-125I in the euthyroid man and rat. J Clin Invest (1969) 1.32
Technical aspects of the estimation of triiodothyronine in human serum: evidence of conversion of thyroxine to triiodothyronine during assay. Metabolism (1971) 1.31
Estimation of thyroxine distribution in man. J Clin Invest (1968) 1.24
Contribution of methodological artifacts to the measurement of T3 concentration in serum. J Clin Endocrinol Metab (1971) 1.22
Metabolism of L-thyroxine (T4) and L-triiodothyronine (T3) by human fibroblasts in tissue culture: evidence for cellular binding proteins and conversion of T4 to T3. Endocrinology (1972) 1.18
Radioimmunoassay for triiodothyronine (T 3 ): I. Affinity and specificity of the antibody for T 3 . J Clin Endocrinol Metab (1971) 1.09
Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J Clin Invest (1973) 1.08
Conversion of thyroxine to triiodothyronine by cultured human cells. Science (1973) 1.06
Derivation of a three compartment model describing disappearance of plasma insulin-131-I in man. J Clin Invest (1969) 1.04
Thyroxine Turnover and Transport in Laennec's Cirrhosis of the Liver. J Clin Invest (1967) 1.02
Extrathyroidal conversion of thyroxine to triiodothyronine in sheep. Endocrinology (1972) 0.92
Metabolic clearance rate of L-triiodothyronine in man: a comparison of results by single-injection and constant infusion methods. J Clin Endocrinol Metab (1971) 0.90
Spontaneous deiodination of I-131-labeled thyroxine and related iodophenols on filter paper. Endocrinology (1963) 0.86
CLINICAL STUDIES ON THE METABOLISM OF 131-I-LABELED L-THYROXINE. J Clin Endocrinol Metab (1964) 0.86
Triiodothyronine turnover in euthyroid subjects. J Clin Endocrinol Metab (1971) 0.81
Thyroxine turnover and transport in diabetes mellitus. J Clin Endocrinol Metab (1973) 0.78
Simultaneous comparative studies of thyroxine and tri-iodothyronine distribution and disposal rates. J Endocrinol (1971) 0.78
Estimation of the triodothyronine secretion rate in euthyroid man. J Clin Endocrinol Metab (1972) 0.77
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91
Preparation of isotopically labeled ribonucleotides for multidimensional NMR spectroscopy of RNA. Nucleic Acids Res (1992) 3.29
Role of penicillinase plasmids in the stability of the mecA gene in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1990) 2.93
Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest (1993) 2.64
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol (1996) 2.58
Neonatal sunburn and melanoma in mice. Nature (2001) 2.25
The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology (2000) 2.08
Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group. Ann Intern Med (1998) 2.01
Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol (1989) 1.97
Sclerosing therapy of internal hemorrhoids with a novel sclerosing agent. Comparison with ligation and excision. Int J Colorectal Dis (2005) 1.91
Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets. J Exp Med (1998) 1.89
[Synthesis and bronchodilating activity of o-chloro-alpha-(tert-butylaminomethyl)-benzylalcohol hydrochloride (C-78) and related compounds (author's transl)]. Yakugaku Zasshi (1978) 1.87
Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology (1998) 1.75
Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood (1997) 1.72
Techniques, indications and results of intraoperative radiotherapy of advanced cancers. Radiology (1975) 1.62
A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem (1997) 1.61
Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (1997) 1.58
Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J Biol Chem (1999) 1.57
Fluorescence-quenching phenomenon by photoinduced electron transfer between a fluorescent dye and a nucleotide base. Anal Sci (2001) 1.55
c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res (1998) 1.54
Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med (1980) 1.53
Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke (1976) 1.52
Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product. Immunogenetics (2000) 1.51
Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci U S A (1997) 1.51
Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice. J Biol Chem (2000) 1.51
Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res (2001) 1.50
Invasion of the lacrimal system by basal cell carcinoma. Dermatol Surg (1999) 1.49
Cystic papillary carcinoma of the thyroid gland: a new sonographic sign. Clin Radiol (1991) 1.49
Right ventricular ejection fraction during exercise in patients with recent myocardial infarction: effect of the interventricular septum. Am Heart J (1994) 1.49
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial. Br J Cancer (2001) 1.47
Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest (1995) 1.47
Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost (1998) 1.46
Clinical long-term results of vascular prosthesis sealed with fragmented autologous adipose tissue. Artif Organs (2001) 1.45
The role of infarction-associated pericarditis on the occurrence of atrial fibrillation. Eur Heart J (1998) 1.43
Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab (1978) 1.42
Antigen receptor-regulated exocytosis in cytotoxic T lymphocytes. J Exp Med (1987) 1.39
Radioiodine uptake by squamous-cell carcinoma of the lung. J Nucl Med (1994) 1.39
Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma. J Nucl Med (1997) 1.39
V-Y advancement posterior thigh fasciocutaneous flaps for total anal canal and large perianal defects. Ann Plast Surg (1996) 1.39
Neurogenic bladder induced by brain abscess. Br J Urol (1995) 1.38
Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest (1998) 1.37
Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes. Nature (1987) 1.37
Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ (1996) 1.36
Activity and toxicity of bleomycin. J Antibiot (Tokyo) (1967) 1.35
Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem (1997) 1.35
Thyroxine transport in thyrotoxicosis and hypothyroidism. J Clin Invest (1967) 1.35
A mesenteric liposarcoma with production of granulocyte colony-stimulating factor. Intern Med (1998) 1.34
Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone (1995) 1.32
Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. Eur J Pharmacol (1996) 1.29
Sonography of Hashimoto's thyroiditis. J Clin Ultrasound (1986) 1.28
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res (1999) 1.26
Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J Biol Chem (1994) 1.25
Malignant ameloblastoma with pulmonary metastasis and hypercalcemia. Report of an autopsy case and review of the literature. Am J Clin Pathol (1988) 1.24
Stress thallium-201 transaxial emission computed tomography: quantitative versus qualitative analysis for evaluation of coronary artery disease. J Am Coll Cardiol (1984) 1.23
Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett (1995) 1.22
Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol (2001) 1.22
Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res (1998) 1.22
Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J Natl Cancer Inst (2001) 1.21
A New Indole Alkaloid, 7 alpha-Hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand. Planta Med (1994) 1.20
alpha-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn (1993) 1.19
Dietary risk factors of stroke and hypertension in Japan -- Part 1: Methodological assessment of urinalysis for dietary salt and protein intakes. Jpn Circ J (1982) 1.19
Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification. Br J Cancer (2006) 1.18
Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res (1998) 1.17
Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transplant (2011) 1.17
Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res (1993) 1.17
Dual-site thyroid ectopy in a mother and son. Thyroid (1992) 1.16
Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells. Cell Microbiol (2005) 1.16
The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia (1999) 1.15
Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. J Bone Miner Res (1996) 1.15
Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies. Clin Endocrinol (Oxf) (1988) 1.15
Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent. Nucl Med Commun (1988) 1.15
Centrilobular lesions of the lung: demonstration by high-resolution CT and pathologic correlation. Radiology (1986) 1.14
TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids. FEBS Lett (1986) 1.13
Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner (1986) 1.13
Antigen receptor-triggered secretion of a trypsin-type esterase from cytotoxic T lymphocytes. J Immunol (1987) 1.12
Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res (1995) 1.11
Perineural and neural involvement in skin cancers. Dermatol Surg (1997) 1.09
Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer (2007) 1.09
Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J Clin Invest (1995) 1.09
Ovarian cystic teratomas: MR imaging. Radiology (1987) 1.08
Segmental analysis of stress thallium myocardial emission tomography for localization of coronary artery disease. Eur J Nucl Med (1984) 1.08
Diverticular disease of the colon at a regional general hospital in Japan. Dis Colon Rectum (1995) 1.07
Histopathological analysis of sixteen subcutaneous rheumatoid nodules. Acta Pathol Jpn (1980) 1.05
Mouth-opening increases upper-airway collapsibility without changing resistance during midazolam sedation. J Dent Res (2004) 1.05
A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase. J Clin Endocrinol Metab (1982) 1.04
Twin-stage procedure. Part 1: A new method to reproduce precise eccentric occlusal relations. Int J Periodontics Restorative Dent (1997) 1.04
Differential expression of calmodulin-binding proteins in B, T lymphocytes and thymocytes. Nature (1987) 1.04
Femoral and spinal bone mineral density in Japanese osteoporotics with hip fracture. Osteoporos Int (1994) 1.04
Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity. J Immunol (1994) 1.04
Scanning electron microscopy detects bacteria within infection stones. J Urol (1984) 1.03
Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. J Clin Endocrinol Metab (1988) 1.03
The eyeless homeodomain is dispensable for eye development in Drosophila. Genes Dev (2001) 1.03
Conversion of brain SPECT images between different collimators and reconstruction processes for analysis using statistical parametric mapping. Nucl Med Commun (2004) 1.03
Effect of mandibular position on upper airway collapsibility and resistance. J Dent Res (2005) 1.03
Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema. J Clin Endocrinol Metab (1983) 1.02
Therapeutic angiogenesis by autologous bone-marrow transplantation in a general hospital setting. Eur J Vasc Endovasc Surg (2003) 1.02